Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05623241 | MONOCENTRIC PERSPECTIVE STUDY: USE OF LIQUID BIOPSY WITH DIAGNOSTIC IMAGING | unknown | — | 200 | University of Campania Luigi VanvitelliOTHER | 1 | Nov 21, 2022 | clinicaltrials |
| NCT00887380 | STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)(STARS) | unknown | Phase 3 | 2,023 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Nov 18, 2022 |
| clinicaltrials |
| NCT05621434 | A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer | unknown | Phase 2 | 63 | Fujian Medical UniversityOTHER | 0 | Nov 18, 2022 | clinicaltrials |
| NCT05622227 | 68Ga PET/CT Imaging in Breast Cancer Patients | unknown | Phase 1 / Phase 2 | 50 | Peking Union Medical College HospitalOTHER | 1 | Nov 18, 2022 | clinicaltrials |
| NCT04996615 | Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening Breast Cancer in High-risk Women | unknown | — | 5,000 | Peking University People's HospitalOTHER | 1 | Nov 16, 2022 | clinicaltrials |
| NCT04288141 | A Study to Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted Therapies(HERdi PREDICT) | unknown | — | 40 | King's College LondonOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT05613270 | Characterizing Breast Cancer With 18F-FES PET/CT | unknown | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT04929197 | Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D Printing(PERSBRA) | unknown | N/A | 50 | Taipei Medical University HospitalOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT05393947 | Investigation of the Effect of Education on Symptom Management on Symptom Management in Patients With Breast Cancer | unknown | N/A | 52 | Saglik Bilimleri UniversitesiOTHER | 1 | Nov 8, 2022 | clinicaltrials |
| NCT01711710 | Clinical Trial to Evaluate the Safety and Efficacy of Breast Implant | unknown | N/A | 103 | Seoul National University HospitalOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT05411380 | Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor. | unknown | Phase 2 | 73 | wang shusenOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT05605808 | Aerobic Training and Diet on the Immune System in Postmastectomy Patients Receiving Chemotherapy | unknown | N/A | 60 | Cairo UniversityOTHER | 1 | Nov 4, 2022 | clinicaltrials |
| NCT03516253 | Fish Oil and EPO in Breast Cancer | unknown | N/A | 60 | University of BelgradeOTHER | 1 | Nov 3, 2022 | clinicaltrials |
| NCT00986661 | A Study to Assess PV-10 Chemoablation of Cancer of the Liver | unknown | Phase 1 | 78 | Provectus Biopharmaceuticals, Inc.INDUSTRY | 1 | Nov 2, 2022 | clinicaltrials |
| NCT02661204 | Diagnostic Performance of an Automated Breast Ultrasound System (ABUS) | unknown | — | 250 | University of ZurichOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT04586517 | Effect of Heavy-load Resistance Training During Chemotherapy on Muscle Cellular Outcomes | unknown | N/A | 40 | Uppsala UniversityOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05103644 | Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients" | unknown | Phase 2 / Phase 3 | 60 | Beni-Suef UniversityOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05444101 | Optimizing Psychological Treatment for Pain After Breast Cancer | unknown | N/A | 185 | University of AarhusOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05602792 | A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 233 | ImmVira Pharma Co. LtdINDUSTRY | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05603013 | Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0) | unknown | Phase 2 | 45 | Second Affiliated Hospital of Soochow UniversityOTHER | 1 | Nov 2, 2022 | clinicaltrials |
| NCT04781062 | Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer(RENOVATE) | unknown | N/A | 367 | Ospedale Policlinico San MartinoOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT03907800 | Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer(NeoPATH) | unknown | Phase 2 | 100 | Ruijin HospitalOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT05595109 | Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients | unknown | Phase 2 / Phase 3 | 56 | Tanta UniversityOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05586659 | Epidemiology of TNBC in Asyut Clinical Oncology Department | unknown | — | 50 | Assiut UniversityOTHER | 0 | Oct 19, 2022 | clinicaltrials |
| NCT01765049 | Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor(DEAR) | unknown | — | 260 | Seoul National University HospitalOTHER | 1 | Oct 18, 2022 | clinicaltrials |
| NCT04809844 | Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer | unknown | — | 46 | Assiut UniversityOTHER | 0 | Oct 18, 2022 | clinicaltrials |
| NCT03105570 | The Oncological Safety and Cosmetic Outcome of Areola Sparing Mastectomy : a Single Arm, Prospective, Cohort Study | unknown | N/A | 145 | Peking University People's HospitalOTHER | 1 | Oct 17, 2022 | clinicaltrials |
| NCT05580887 | Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients | unknown | — | 35 | Moscow Clinical Scientific CenterOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT04192331 | Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer | unknown | Phase 2 | 97 | Peking University Cancer Hospital & InstituteOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT05577923 | Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower) | unknown | Phase 2 | 126 | Fudan UniversityOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT03992521 | Breast Cancer Liquid Biopsy Stratification(BALIBISTRA) | unknown | — | 59 | Medical University of GrazOTHER | 1 | Oct 10, 2022 | clinicaltrials |
| NCT05566457 | HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC | unknown | Phase 2 | 92 | Chinese Academy of Medical SciencesOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT05566613 | Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer Patients(SENS) | unknown | — | 550 | Karolinska University HospitalOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT03713255 | Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial | unknown | N/A | 150 | Ottawa Hospital Research InstituteOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT04331535 | The Genomic Medicine at VA Study(GenoVA) | unknown | N/A | 1,076 | Boston VA Research Institute, Inc.OTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT05561686 | Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer | unknown | — | 100 | Hunan Cancer HospitalOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT05085626 | Fluzoparib in Combination With Chidamide or Camrelizumab for HRD Positive HER2 Negative Advanced Breast Cancer | unknown | Phase 2 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 29, 2022 | clinicaltrials |
| NCT05559528 | BRaziLian outcomE for metAStatic breasT Cancer(BREAST) | unknown | — | 300 | Hospital do CoracaoOTHER | 1 | Sep 29, 2022 | clinicaltrials |
| NCT05560334 | A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations | unknown | Phase 2 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Sep 29, 2022 | clinicaltrials |
| NCT05518292 | Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery | unknown | Phase 2 / Phase 3 | 60 | Mansoura UniversityOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT05558917 | Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery(ESPECS) | unknown | N/A | 160 | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di AlessandriaOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT05550090 | Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC(DreaminLMBC) | unknown | — | 40 | Zhejiang Cancer HospitalOTHER | 1 | Sep 27, 2022 | clinicaltrials |
| NCT05494281 | Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer(USB22) | unknown | N/A | 94 | Moroccan Society of SurgeryOTHER | 1 | Sep 22, 2022 | clinicaltrials |
| NCT05504148 | Protection of Cardiovascular Function With Crocin in BrEast Cancer Patients Undergoing Radiotherapy and Chemotherapy(ProtECtion) | unknown | N/A | 120 | Qilu Hospital of Shandong UniversityOTHER | 1 | Sep 22, 2022 | clinicaltrials |
| NCT05398497 | FreezIng bReaST Cancer in Brazil: a Before-after Study(FIRST) | unknown | N/A | 30 | Hospital do CoracaoOTHER | 1 | Sep 21, 2022 | clinicaltrials |
| NCT05359120 | Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE) | unknown | — | 300 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 19, 2022 | clinicaltrials |
| NCT05546255 | Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 19, 2022 | clinicaltrials |
| NCT05357417 | Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases | unknown | Phase 2 | 100 | Henan Cancer HospitalOTHER_GOV | 1 | Sep 16, 2022 | clinicaltrials |
Data updated 24 days agoSource updated Nov 21, 2022source: clinicaltrials